AMD’s Ambitious Push into AI Market Against Nvidia

AMD challenges Nvidia's dominance in Artificial Intelligence with strategic chip advancements and software expansion.

Under Lisa Su’s leadership, Advanced Micro Devices (AMD) has achieved significant growth, transforming from near bankruptcy to surpassing Intel in market value. Now, Su aims to challenge Nvidia’s dominance in the Artificial Intelligence (AI) sector. As the only viable alternative to Nvidia, AMD is working to enlarge its share of the AI market, emphasizing high-performance chip development.

A key factor in AMD’s strategy is its annual introduction of new AI chips and the expansion of its software division to rival Nvidia’s CUDA with its own free-to-use ROCm platform. AMD’s commitment to open-source tools supports its push to attract developers who are seeking alternatives to Nvidia’s established ecosystem. Despite having competitive hardware, AMD’s main challenge lies in overcoming the software inertia that favors Nvidia.

Central to Su’s approach is a deep involvement in technical decisions aimed at long-term innovation. While AMD’s AI sales are significant, and the company anticipates market growth, Su emphasizes making ‘the right bets’ for sustainable success in the tech industry. This includes embracing chiplet technology to enhance manufacturing flexibility, helping AMD leverage its designs for AI and data center applications effectively.

76

Impact Score

Nvidia prepares PC return with Arm and x86 chip collaborations

Nvidia is preparing a return to the consumer PC market through new system-on-a-chip designs built with MediaTek Arm processors and separate x86 efforts tied to Intel, creating a potentially complex, dual-track strategy for Windows devices.

India’s role in pharma’s shift to Artificial Intelligence led platform models

Global pharma is moving from linear drug development to Artificial Intelligence led, platform-based models that tightly integrate discovery, data and manufacturing, opening a strategic window for India to move beyond cost-led scale. India’s opportunity lies in building integrated biopharma systems where science, digital intelligence and modular manufacturing are orchestrated from the outset.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.